A Phase 1 interventional study of 177Lu-PSMA-617 and 225Ac-PSMA-617 in prostate cancer

Recruiting Phase 1 NCT07054346

Study Description

Comparing the effects of two radioligand therapies in high-risk prostate cancer before surgery

Study Details

Registry ID:: NCT07054346
Conditions:: Prostate Cancer, Prostate Cancer (Diagnosis), High-risk Prostate Cancer, Localized Prostate Carcinoma, Very High Risk Prostate Carcinoma
Phase:: Phase 1
Target Enrollment:: 45 participants
Start Date:: July 8, 2025
Healthy Volunteers:: No

Study Locations (1 site)

University of California, San Francisco
San Francisco, CaliforniaUnited States, United States

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →